CN115605752A - 快速细胞内测定 - Google Patents
快速细胞内测定 Download PDFInfo
- Publication number
- CN115605752A CN115605752A CN202080097256.2A CN202080097256A CN115605752A CN 115605752 A CN115605752 A CN 115605752A CN 202080097256 A CN202080097256 A CN 202080097256A CN 115605752 A CN115605752 A CN 115605752A
- Authority
- CN
- China
- Prior art keywords
- intracellular
- sample
- disease
- cell
- biomarker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003834 intracellular effect Effects 0.000 title claims description 109
- 238000003556 assay Methods 0.000 title description 20
- 239000000090 biomarker Substances 0.000 claims abstract description 104
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 60
- 201000010099 disease Diseases 0.000 claims abstract description 56
- 239000000523 sample Substances 0.000 claims description 159
- 210000004027 cell Anatomy 0.000 claims description 123
- 210000004369 blood Anatomy 0.000 claims description 85
- 239000008280 blood Substances 0.000 claims description 85
- 210000000265 leukocyte Anatomy 0.000 claims description 51
- 238000010186 staining Methods 0.000 claims description 51
- 238000003384 imaging method Methods 0.000 claims description 38
- 239000007795 chemical reaction product Substances 0.000 claims description 26
- 238000003745 diagnosis Methods 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 238000010212 intracellular staining Methods 0.000 claims description 17
- 238000004458 analytical method Methods 0.000 claims description 16
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 14
- 239000002751 oligonucleotide probe Substances 0.000 claims description 14
- 108020004999 messenger RNA Proteins 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 11
- 239000012128 staining reagent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 208000023275 Autoimmune disease Diseases 0.000 claims description 5
- 208000035473 Communicable disease Diseases 0.000 claims description 5
- 206010036790 Productive cough Diseases 0.000 claims description 5
- 210000003714 granulocyte Anatomy 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 230000003211 malignant effect Effects 0.000 claims description 5
- 210000003802 sputum Anatomy 0.000 claims description 5
- 208000024794 sputum Diseases 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 5
- 239000012472 biological sample Substances 0.000 claims description 4
- 208000030159 metabolic disease Diseases 0.000 claims description 4
- 238000013188 needle biopsy Methods 0.000 claims description 4
- 238000009595 pap smear Methods 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims 5
- 239000007853 buffer solution Substances 0.000 claims 3
- 239000008191 permeabilizing agent Substances 0.000 claims 3
- 208000026350 Inborn Genetic disease Diseases 0.000 claims 2
- 208000031951 Primary immunodeficiency Diseases 0.000 claims 2
- 208000026723 Urinary tract disease Diseases 0.000 claims 2
- 208000016361 genetic disease Diseases 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 208000014001 urinary system disease Diseases 0.000 claims 2
- 208000037273 Pathologic Processes Diseases 0.000 claims 1
- 208000006593 Urologic Neoplasms Diseases 0.000 claims 1
- 208000012931 Urologic disease Diseases 0.000 claims 1
- 210000000941 bile Anatomy 0.000 claims 1
- 210000002726 cyst fluid Anatomy 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 210000004251 human milk Anatomy 0.000 claims 1
- 235000020256 human milk Nutrition 0.000 claims 1
- 230000009054 pathological process Effects 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 8
- 238000011246 intracellular protein detection Methods 0.000 abstract description 5
- 238000012544 monitoring process Methods 0.000 abstract description 5
- 125000006850 spacer group Chemical group 0.000 description 41
- 239000012192 staining solution Substances 0.000 description 41
- 102000004889 Interleukin-6 Human genes 0.000 description 37
- 108090001005 Interleukin-6 Proteins 0.000 description 37
- 238000001514 detection method Methods 0.000 description 30
- 239000002158 endotoxin Substances 0.000 description 26
- 229920006008 lipopolysaccharide Polymers 0.000 description 26
- 238000009396 hybridization Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 102000004388 Interleukin-4 Human genes 0.000 description 13
- 108090000978 Interleukin-4 Proteins 0.000 description 13
- 108091070501 miRNA Proteins 0.000 description 13
- 238000002965 ELISA Methods 0.000 description 11
- 239000012491 analyte Substances 0.000 description 11
- 238000005070 sampling Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 210000002919 epithelial cell Anatomy 0.000 description 10
- 201000008827 tuberculosis Diseases 0.000 description 10
- 208000022362 bacterial infectious disease Diseases 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000002073 fluorescence micrograph Methods 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 208000035143 Bacterial infection Diseases 0.000 description 8
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 241000725303 Human immunodeficiency virus Species 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 208000036142 Viral infection Diseases 0.000 description 6
- BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 description 6
- 230000002596 correlated effect Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 241000712461 unidentified influenza virus Species 0.000 description 6
- 230000009385 viral infection Effects 0.000 description 6
- 208000025721 COVID-19 Diseases 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 239000005090 green fluorescent protein Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 210000001616 monocyte Anatomy 0.000 description 5
- 230000000737 periodic effect Effects 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 4
- 108091005461 Nucleic proteins Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000104 diagnostic biomarker Substances 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 3
- 208000009608 Papillomavirus Infections Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 208000036981 active tuberculosis Diseases 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 208000037765 diseases and disorders Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000008823 permeabilization Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002331 protein detection Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000012099 Alexa Fluor family Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 101001003584 Homo sapiens Prelamin-A/C Proteins 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 102100026531 Prelamin-A/C Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 210000004241 Th2 cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012137 double-staining Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 108010027225 gag-pol Fusion Proteins Proteins 0.000 description 2
- 210000000224 granular leucocyte Anatomy 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 238000010295 mobile communication Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 101100437895 Alternaria brassicicola bsc3 gene Proteins 0.000 description 1
- 241000112287 Bat coronavirus Species 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010027044 HIV Core Protein p24 Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 101150073872 ORF3 gene Proteins 0.000 description 1
- 101100226891 Phomopsis amygdali PaP450-1 gene Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940028885 interleukin-4 Drugs 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 108091045440 let-7a-1 stem-loop Proteins 0.000 description 1
- 108091047626 let-7a-2 stem-loop Proteins 0.000 description 1
- 108091047557 let-7a-3 stem-loop Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108091090860 miR-150 stem-loop Proteins 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/302—Stain compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (23)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962951949P | 2019-12-20 | 2019-12-20 | |
US62/951,949 | 2019-12-20 | ||
PCT/US2020/066499 WO2021127664A1 (en) | 2019-12-20 | 2020-12-21 | Rapid intra-cellular assay |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115605752A true CN115605752A (zh) | 2023-01-13 |
Family
ID=76478054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080097256.2A Pending CN115605752A (zh) | 2019-12-20 | 2020-12-21 | 快速细胞内测定 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20230400469A1 (zh) |
CN (1) | CN115605752A (zh) |
WO (1) | WO2021127664A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114113609A (zh) * | 2021-11-30 | 2022-03-01 | 河北医科大学第二医院 | Gfap和cntn1在制备用于胶质母细胞瘤早期筛查和早期诊断试剂盒中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7531362B2 (en) * | 2001-06-07 | 2009-05-12 | Medmira Inc. | Rapid diagnostic assay |
CA2634522C (en) * | 2005-12-21 | 2015-09-29 | Meso Scale Technologies, Llc | Assay modules having assay reagents and methods of making and using same |
EP2904389A4 (en) * | 2012-10-01 | 2016-07-06 | Univ Princeton | MICROFLUIDIC SENSORS WITH ENHANCED OPTICAL SIGNALS |
US20200406254A1 (en) * | 2017-02-08 | 2020-12-31 | Essenlix Corporation | Q-max card-based assay devices and methods |
CN112236451A (zh) * | 2017-10-26 | 2021-01-15 | Essenlix公司 | 引起性传播疾病的细菌和免疫t细胞检测 |
-
2020
- 2020-12-21 CN CN202080097256.2A patent/CN115605752A/zh active Pending
- 2020-12-21 US US17/787,804 patent/US20230400469A1/en active Pending
- 2020-12-21 WO PCT/US2020/066499 patent/WO2021127664A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021127664A1 (en) | 2021-06-24 |
US20230400469A1 (en) | 2023-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Makler et al. | A review of practical techniques for the diagnosis of malaria | |
CN111226113B (zh) | Qmax测定及应用(ii) | |
JP6962914B2 (ja) | チップ、検出器、ならびにそれらの製造方法および使用方法 | |
KR102236276B1 (ko) | 반응과 분석을 포함한 단일 진단칩의 고감도 신속진단방법 | |
US10060905B2 (en) | Liquid medium and sample vial for use in a method for detecting cancerous cells in a cell sample | |
EP2414537B1 (en) | Detection of infectious disease in a human or animal by measuring specific phagocytosis in a thin film sample of their anticoagulated blood | |
CN102246040B (zh) | 用于诊断结核病的方法和装置 | |
EP1015914A2 (en) | Microscope slide | |
EP1754041A1 (en) | Method and device for rapid detection and quantitation of macro and micro matrices | |
JP2676108B2 (ja) | 血液滴または任意の生物媒質に由来する液からの物質の免疫酵素的検出装置 | |
WO2021097492A1 (en) | Rapid intra-cellular assay and use of the same | |
JP2021103183A (ja) | アナライトの検出およびそのための方法 | |
WO2020038235A1 (zh) | 基于平面波导技术的高通量生物、化学、环境检测系统和方法 | |
CN115605752A (zh) | 快速细胞内测定 | |
Yang et al. | An immunoassay cassette with a handheld reader for HIV urine testing in point-of-care diagnostics | |
Zhou et al. | Development and prospects of microfluidic platforms for sperm inspection | |
WO2020049444A1 (en) | A device and a lateral flow assay method for differential identification of plasmodium species | |
US20230221319A1 (en) | A Method, A System, An Article, A Kit And Use Thereof For Biomolecule, Bioorganelle, Bioparticle, Cell And Microorganism Detection | |
CN117110604A (zh) | 检测新冠病毒抗原的免疫层析试纸条 | |
GB2521885A (en) | An immunoassay detection device | |
CN111458500A (zh) | 人呼吸道上皮细胞病原细胞学检测方法及试剂盒 | |
WO2018056700A1 (ko) | 반응과 분석을 포함한 단일 진단칩의 고감도 신속진단방법 | |
Hwang et al. | Biosensor-Based Point-of-Care Devices: Detection of Infectious Diseases and Cancer | |
Patwardhan et al. | Laboratory diagnosis of spinal tuberculosis: past and present | |
CN116482358A (zh) | 一种基于流式细胞术判读因结核致敏分泌干扰素的t淋巴细胞数量的方法及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231112 Address after: 200245 Room 409, 4th Floor, Building 2, No. 1508 Kunyang Road, Minhang District, Shanghai Applicant after: Shanghai Yisheng Biotechnology Co.,Ltd. Address before: Unit B, 14th Floor, Wing Cheung Commercial Building, 19-25 Suhang Street, Sheung Wan, Hong Kong, China Applicant before: Yewei Co.,Ltd. Effective date of registration: 20231112 Address after: Unit B, 14th Floor, Wing Cheung Commercial Building, 19-25 Suhang Street, Sheung Wan, Hong Kong, China Applicant after: Yewei Co.,Ltd. Address before: Zhang Keshen, New Jersey, USA Applicant before: Essenlix |
|
TA01 | Transfer of patent application right |